Munich Startup
neurotrim Systems GmbH

neurotrim Systems GmbH

At neurotrim Systems, we believe it’s time for therapy 4.0. In Germany alone, re-injuries to the ankle, knee, hip, and back cost over 1 billion euros annually. The causes are inadequate measurements and lack of objectivity i...

Founded2026
Business ModelB2B
IndustryHealth
This content was machine translated.

About neurotrim Systems GmbH

At neurotrim Systems, we believe it’s time for therapy 4.0. In Germany alone, re-injuries to the ankle, knee, hip, and back cost over 1 billion euros annually. The causes are inadequate measurements and lack of objectivity in physiotherapy, as well as rigid and insufficiently personalized therapy protocols. Our N1.System combines diagnostics and therapy in an easy-to-use, AI-based software-hardware solution. Hundreds of measurement points per second from pressure, motion, and image sensors provide a complete picture of the patient. Pattern recognition offers insights into compensatory and protective postures, as well as insufficient muscle control and activation. Exercises directly on the N1.System provide individualized and safe therapy protocols that should prevent up to 25% of subsequent injuries depending on the indication. Our solution is based on 10 years of development of the neurotrim method by Michael Schiff – father of CEO and co-founder Maximilian. We know: rehabilitation of the lower extremities is just the beginning. Successful treatments in geriatrics, for multiple sclerosis, and for performance enhancement in sports reveal immense potential for the future. The N1.System is offered in a licensing model to professional sports clubs and – after successful certification as a medical device – to clinics and rehabilitation centers (HealthCare/MedTech – B2B).

More like this

Discover relevant articles, startups, and events from the ecosystem

Devanthro

Devanthro puts an end to household chores. The Munich-based physical AI company develops humanoid robots for private residential spaces, starting with elderly care—a market under acute pressure due to a critical shortage of 4.3 million care workers across Europe. The Robody platform has been deployed in real apartments since 2024, making Devanthro the first and only company so far with humanoids that can be legally used in domestic environments. In January 2026, a Robody became the world’s first humanoid robot to care for a person with dementia at home. Devanthro now works with Germany’s largest care providers to offer their clients the Robody care and support service, with validated reimbursement pathways. The strategy leverages a data advantage: deployments in home care generate training data from the environments that matter (real living rooms, not factory floors). Care is the entry point. The goal is a Robody in every home, giving every family back the thousand hours a year that household chores take from them.

OtherHealth

2026Founded
-Team size
Startup Stage